An interesting example is the overexpression of CXCL12 in DCIS as well as invasive cancer, a chemokine that has been shown to increase the expression of DYX1C1 in a prostate epithelial cell line [27]. Here, CXCL12 is linked to ductal breast carcinoma in situ.